The Importance of Supply Security
The COVID-19 pandemic worldwide has caused immense strain on the pharmaceutical supply chain.
Current realities include:
-
Increased sensitivity over origins of Active Pharmaceutical Ingredients (API)
-
Providing transparency over sourcing of Key Starting Materials (KSM) - origins, gluten/lactose/dye free
-
Heightened transparency over adequate supply of API and safety stock.
-
Shelf-life of product
-
Supply Chain Consistency/readiness
-
Serialization readiness
-
Customers increasing interest in diversifying their supply risk with high volume categories (e.g. women’s health – thyroid) to minimize service disruptions with incumbent suppliers
Provell Pharmaceuticals stands ready to meet and exceed these expectations of our customers and patients.
Provell is committed to:
-
Only source products with API/KSM from countries within Europe
-
Maintain at minimum an adequate supply of product to meet existing demand and allocate additional stock to cover for potential supply disruptions (‘levo-insurance’)
-
Utilize high quality standards and control in the manufacturing and distribution of our products throughout the United States.
Learn how Provell is providing the United States the leading dispensed brand [1] of levothyroxine worldwide at a generic price to mitigate supply chain risk in these challenging times.
[1] Source: Data on file – IQVIA Q4 - 2021